Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Halozyme Therapeutics Inc.’s stock clocked out at $50.59, down -0.10% from its previous closing price of $50.64. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 0.74 million shares were traded. HALO stock price reached its highest trading level at $51.08 during the session, while it also had its lowest trading level at $50.03.
Ratios:
To gain a deeper understanding of HALO’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.70. For the most recent quarter (mrq), Quick Ratio is recorded 6.21 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 5.19 whereas as Long-Term Debt/Eq ratio is at 5.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on October 07, 2024, Downgraded its rating to Equal Weight and sets its target price to $62 from $58 previously.
On September 19, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also upped its target price recommendation from $52 to $57.
Piper Sandler Downgraded its Overweight to Neutral on June 07, 2024, whereas the target price for the stock was revised from $48 to $51.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 15 ’24 when LaBarre Michael J. sold 10,000 shares for $53.75 per share. The transaction valued at 537,469 led to the insider holds 173,756 shares of the business.
LaBarre Michael J. sold 10,000 shares of HALO for $532,590 on Oct 16 ’24. The SVP, CHIEF TECHNICAL OFFICER now owns 173,756 shares after completing the transaction at $53.26 per share. On Oct 16 ’24, another insider, MICHAEL LABARRE, who serves as the Officer of the company, bought 10,000 shares for $53.26 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HALO now has a Market Capitalization of 6414963712 and an Enterprise Value of 7412803072. As of this moment, Halozyme’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.61, and their Forward P/E ratio for the next fiscal year is 11.12. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.85. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.34 while its Price-to-Book (P/B) ratio in mrq is 22.12. Its current Enterprise Value per Revenue stands at 8.488 whereas that against EBITDA is 15.418.
Stock Price History:
Over the past 52 weeks, HALO has reached a high of $65.53, while it has fallen to a 52-week low of $33.07. The 50-Day Moving Average of the stock is -11.70%, while the 200-Day Moving Average is calculated to be 6.14%.
Shares Statistics:
It appears that HALO traded 1.33M shares on average per day over the past three months and 962980 shares per day over the past ten days. A total of 126.77M shares are outstanding, with a floating share count of 125.30M. Insiders hold about 1.09% of the company’s shares, while institutions hold 100.24% stake in the company. Shares short for HALO as of 1728950400 were 10416746 with a Short Ratio of 7.83, compared to 1726185600 on 9635995. Therefore, it implies a Short% of Shares Outstanding of 10416746 and a Short% of Float of 11.14.
